American Portfolios Advisors Tg Therapeutics, Inc. Transaction History

American Portfolios Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Mar 20, 2023	BUY	$3.74 - $10.66 $785 - $2,238	210 New	210 $893,000
Q1 2022 Mar 21, 2023	BUY	$7.81 - $20.45 $1,640 - $4,294	210 New	210 $2 Million
Q4 2021 Mar 21, 2023	BUY	$15.2 - $35.51 $3,192 - $7,457	210 New	210 $3.99 Million
Q3 2021 Mar 22, 2023	BUY	$21.78 - $40.45 $4,573 - $8,494	210 New	210 $6.99 Million
Q2 2021 Mar 22, 2023	BUY	$32.5 - $48.96 $4,062 - $6,120	125 New	125 $4.85 Million

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.